Phase One of the qualitative study was conducted to gather providers’ early insights on virtual care while their patients began enrollment in the program.
Phase Two will be carried out towards the end of the trial period to gain additional perspectives.
A total of 25 primary care providers (PCPs) and four clinical pharmacists were surveyed from November 2023 to February 2024 as part of Phase One, with six of the PCPs also participating in follow-up interviews.
Download the full white paper to learn more.